Bipolar disorder is a serious, long-term, and treatable psychiatric illness, marked by episodes of mania or hypomania alongside episodes of depression. Its treatment rests on medication and regular psychiatric care, and the things you can do yourself support that care rather than replacing it. The best-evidenced foundation is a mood stabilizer, and lithium has the longest record: it lowers the risk of relapse, guards against manic highs more reliably than depressive lows, and is the one mood treatment with trial evidence for reducing suicide.
Antipsychotics bring down acute mania, and several also treat bipolar depression, while lithium, lamotrigine, and quetiapine carry the maintenance phase. One point matters more here than almost anywhere in psychiatry: an antidepressant taken on its own can tip someone with bipolar disorder into mania, so antidepressants are used cautiously and rarely without a mood stabilizer. The strongest lever you hold yourself is protecting sleep and a steady daily rhythm, because sleep loss can trigger mania, and psychoeducation, family involvement, and interpersonal and social rhythm therapy each lower the relapse rate on top of medication.
Findings & Outcomes
What It Is
If you are thinking about suicide right now, or someone is manic and at risk, treat it as a medical emergency.
Contact your local emergency services, or the suicide and crisis line your own country's health service publishes, and if someone is with you, ask them to stay. Those routes are set out again in the "When to See Someone" section below. Asking someone directly whether they are thinking of ending their life does not put the idea there.
Bipolar disorder is a medical illness in which mood, energy, and the ability to function swing between two poles over weeks to months. The manic pole runs high: elevated or irritable mood, racing thoughts, fast speech, inflated confidence, a reduced need for sleep, and impulsive or risky behavior. The depressive pole runs low, in the same way a major depression does. Bipolar I disorder is defined by at least one full manic episode, which can include psychosis and often needs hospital care. Bipolar II disorder involves hypomania, a milder high that does not tip into psychosis or hospitalization, together with depressive episodes that are often the heavier burden. Across the World Health Organization surveys, about 0.6% of people meet criteria for bipolar I over their lifetime and around 2.4% for the wider bipolar spectrum, and most also live with another condition, usually an anxiety disorder.
Bipolar disorder is frequently mistaken for ordinary depression, because people seek help when they are low, not when they feel well or energized. That distinction changes everything about treatment. An antidepressant given for what looks like plain depression can tip a person with underlying bipolar disorder into mania, so the diagnosis has to be got right before the medication is chosen. If low mood is punctuated by spells of unusual energy, little need for sleep, or fast decisions that later look reckless, that history is worth telling a clinician plainly.
This is not a condition that lifestyle alone can hold. The daily levers on this page are real, and they lower the relapse rate, but they work on top of a mood stabilizer and psychiatric care, not instead of them. What follows is what the research supports, in what role, and the Chinese medicine reading alongside it.
What Helps
Bipolar disorder is one of the more treatable serious psychiatric illnesses, and most people reach long stretches of stability with the right combination. The order here reflects how the evidence stacks: a mood stabilizer as the foundation, medication matched to whichever pole is active, the psychosocial therapies that lower relapse on top, and then the self-directed levers, sleep above all. Each finding below is graded at the strength of its own evidence.
The foundation is a mood stabilizer, and lithium has the longest and strongest record. Taken steadily, it cuts the risk of relapse by roughly a third, guarding against manic episodes more reliably than depressive ones, and it is the one mood treatment with randomized evidence pointing to a lower risk of suicide. It asks something in return: periodic blood tests, because the helpful dose sits close to the toxic one, and attention to the thyroid and kidneys over the years. Those cautions sit together in the Cautions section below.
When mania is acute, antipsychotics do the heavy lifting. In the largest comparison, haloperidol, risperidone, and olanzapine ranked most effective at bringing a manic episode down, and antipsychotics as a class outperformed the mood stabilizers for the acute high. For bipolar depression, several atypical antipsychotics beat placebo: lurasidone and quetiapine helped the most people, with lurasidone and cariprazine adding the least weight, so the choice trades benefit against side effects. Lamotrigine gives a modest lift in bipolar depression, clearest in more severe episodes, and helps keep the lows from returning, though it does nothing for mania and must be built up slowly because of a rare serious rash.
Antidepressants are the part most often misunderstood. Added on top of a mood stabilizer they produce only a small improvement in bipolar depression and do not raise the number of people who actually recover, while their prolonged use raises the risk of a manic switch. Taken alone, without a mood stabilizer, an antidepressant triggered a switch into mania or hypomania in a sizeable share of people with bipolar depression, more so than in combination treatment. This is why guidelines lean on the mood stabilizers and antipsychotics for the depressed phase and use antidepressants cautiously, if at all.
Three psychosocial treatments lower the relapse rate on top of medication, and they earn their place:
- Psychoeducation, especially in a structured group, reduces relapse, most clearly the return of manic and mixed episodes, and works best for people earlier in the illness. It teaches the early warning signs, steady routines, and a plan to act on.
- Interpersonal and social rhythm therapy (IPSRT) steadies daily rhythms, sleep, meals, and social routines. It did not speed initial recovery, but people who had it stayed well for longer between episodes.
- Family-focused therapy brings the person and their relatives together for psychoeducation and communication skills, and reduced relapses and rehospitalizations over two years.
The strongest lever you hold yourself is sleep and a regular daily rhythm. Disrupted sleep both predicts and can precipitate mania: a change in the sleep pattern often comes before a change in mood, and losing sleep can tip some people into a manic episode. Protecting a steady sleep and wake time is treated as a core priority, both to lower relapse and as an early signal to watch, which is the same circadian logic that IPSRT is built on. Omega-3 fatty acids, added to standard treatment, give a small improvement in bipolar depression and nothing for mania, on thin evidence, so they sit as a low-risk adjunct rather than a treatment.
The Research & Studies
Everything here is based on the research we have collected and checked, sorted into groups and ordered with the strongest evidence first. Click any claim to open the studies behind it.
Mood & stress
Lithium cut bipolar relapse by about a third, more clearly for mania than depression
Taken steadily, lithium makes a return of illness less likely, cutting the risk of a relapse by roughly a third. It guards against the manic highs more reliably than the lows.
Across randomized maintenance trials, lithium was more effective than placebo at preventing relapse to any mood episode, with a random-effects relative risk of about 0.65 (95% CI 0.50 to 0.84). The protective effect was clear for manic relapse and weaker and less certain for depressive relapse. Lithium remains a first-line maintenance treatment in the CANMAT and ISBD guidelines. Measured in: Adults with bipolar disorder in five randomized placebo-controlled maintenance trials, 770 participants. Several older maintenance trials used designs that recruited people already stable on lithium and then withdrew it in the placebo arm, which can exaggerate the apparent benefit; the effect on depressive episodes is the weaker part of the evidence.
The study · 1
Geddes et al., long-term lithium therapy for bipolar disorder, systematic review and meta-analysis of randomized controlled trials · Am J Psychiatry 2004
For acute mania, haloperidol, risperidone and olanzapine ranked most effective
For bringing down an acute manic high, antipsychotic drugs worked better on average than the classic mood stabilizers, with haloperidol, risperidone and olanzapine at the top.
In a network meta-analysis of acute mania, the drugs with the highest probability of being most effective, measured by change on the Young Mania Rating Scale versus placebo, were haloperidol (standardized mean difference -0.56), risperidone (-0.50) and olanzapine (-0.43). Overall, antipsychotics were significantly more effective than mood stabilizers such as lithium and valproate for calming an acute manic episode, though tolerability differed between drugs. Measured in: 16,073 adults with acute mania across 68 randomized controlled trials. Efficacy for the acute episode is not the same as long-term suitability: several of the most effective antimanic drugs carry sedation, movement side effects or metabolic effects that matter over the years someone takes them, and lithium's edge is in maintenance rather than acute mania.
The study · 1
Cipriani et al., comparative efficacy and acceptability of antimanic drugs in acute mania, multiple-treatments meta-analysis · Lancet 2011
For bipolar depression, lurasidone and quetiapine had the best numbers to treat (NNT 5 and 6)
For the depressed phase of bipolar disorder, several antipsychotics work: lurasidone and quetiapine helped the most people, while lurasidone and cariprazine added the least weight.
In a network meta-analysis of the atypical antipsychotics approved for bipolar depression, all of them beat placebo on response (a 50% or greater fall on the Montgomery-Asberg Depression Rating Scale). The number needed to treat for response was lowest for lurasidone (5), then quetiapine (6), olanzapine (10) and cariprazine (12). Lurasidone and cariprazine caused less weight gain than olanzapine and quetiapine, so the choice trades efficacy against side effects. Measured in: adults with bipolar depression across 18 randomized controlled trials of atypical antipsychotic monotherapy (lurasidone, quetiapine, olanzapine, cariprazine, aripiprazole and ziprasidone). These drugs differ sharply in side effects (weight gain, sedation, metabolic effects), so the most effective on paper is not automatically the right choice for a given person, and the trials were acute rather than long-term.
The study · 1
Kadakia et al., efficacy and tolerability of atypical antipsychotics for acute bipolar depression, a network meta-analysis · BMC Psychiatry 2021;21:249
Bipolar spectrum affects about 2.4% of people over a lifetime, bipolar I about 0.6%
Around 1 in 40 people have some form of bipolar disorder over their lifetime, and the classic bipolar I form is closer to 1 in 150. Most people with it also have another condition, usually an anxiety disorder.
In the World Health Organization World Mental Health Survey Initiative, the aggregate lifetime prevalence was 0.6% for bipolar I disorder, 0.4% for bipolar II, 1.4% for subthreshold bipolar, and 2.4% for the bipolar spectrum overall. Three quarters of people with a bipolar spectrum disorder also met criteria for another psychiatric disorder, most often an anxiety disorder (63%). Rates were higher in high-income than low-income countries, but severity and comorbidity were similar across settings, and treatment need was often unmet. Measured in: 61,392 community adults across 11 countries in the Americas, Europe and Asia, assessed with the WHO Composite International Diagnostic Interview version 3.0. What could explain it instead: Prevalence estimates depend on the diagnostic threshold and interview method used, and structured lay-administered interviews can over-count or under-count bipolar spectrum cases relative to clinician diagnosis, which is one reason rates vary widely between countries.. Cross-country estimates ranged widely (from about 0.1% to 3.3%), reflecting real differences and differences in case ascertainment, and a lay-administered interview is not the same as a clinical diagnosis.
The study · 1
Merikangas et al., prevalence and correlates of bipolar spectrum disorder in the World Mental Health Survey Initiative · Arch Gen Psychiatry 2011
Added to a mood stabilizer, antidepressants eased symptoms slightly but did not raise response or remission
Even added on top of a mood stabilizer, antidepressants only nudged bipolar depression a little and did not help more people actually recover, while raising the risk of a manic switch over time.
In randomized placebo-controlled trials, second-generation antidepressants added on top of a mood stabilizer or an antipsychotic produced a small reduction in acute bipolar depression symptoms but did not increase the proportion of people who reached clinical response or remission. Prolonged use was associated with a higher risk of switching into mania or hypomania, so the authors concluded antidepressants have at best a modest short-term role as an add-on, never as sole treatment. Measured in: Adults with acute bipolar depression across randomized double-blind placebo-controlled trials of adjunctive second-generation antidepressants. The trials tested newer antidepressants added to existing treatment, not older classes or monotherapy, and were short-term, so they do not describe long-term maintenance or the higher-risk drugs.
The study · 1
McGirr et al., safety and efficacy of adjunctive second-generation antidepressant therapy with a mood stabiliser or an atypical antipsychotic in acute bipolar depression, systematic review and meta-analysis · Lancet Psychiatry 2016
Lamotrigine modestly helped bipolar depression and prevented depressive relapse
Lamotrigine gives a modest lift in bipolar depression, most in those who are more severely down, and helps keep the lows from coming back. It does not treat mania and has to be built up slowly to avoid a rare dangerous rash.
Pooling individual patient data from five randomized trials, more people responded to lamotrigine than placebo in bipolar depression on both the Hamilton (relative risk 1.27, 95% CI 1.09 to 1.47) and Montgomery-Asberg (1.22, 1.06 to 1.41) depression scales, with a larger effect in people who were more severely depressed at baseline. In maintenance, lamotrigine reduces the risk of a new depressive episode. Its weakness is the manic pole: it does little for acute mania and must be started slowly because of a rare serious rash. Measured in: 1,072 adults with bipolar depression across five randomized placebo-controlled trials (individual patient data). The acute antidepressant effect is modest and clearest in more severe depression; lamotrigine does not treat mania, and it must be titrated slowly to reduce the risk of a serious rash (Stevens-Johnson syndrome).
The study · 1
Geddes et al., lamotrigine for treatment of bipolar depression, independent meta-analysis and meta-regression of individual patient data from five randomised trials · Br J Psychiatry 2009
Group psychoeducation lowered relapse on top of medication
Learning the illness in a structured group, on top of medication, makes relapse less likely, especially the return of highs, and works best for people earlier in the illness.
In a systematic review of randomized controlled trials, structured group psychoeducation added to medication reduced the risk of relapse in bipolar disorder, with the effect clearest for manic and mixed relapse and for people earlier in the illness. Individually delivered psychoeducation showed less consistent benefit. Psychoeducation teaches people to recognize early warning signs, keep regular routines, adhere to treatment, and act on a relapse plan. Measured in: Adults with bipolar disorder across randomized controlled trials of psychoeducation versus usual care or active comparators. The benefit was strongest for group formats and for people not in an acute episode and earlier in the course of illness; it is an add-on to medication, not a replacement, and trials varied in content and length.
The study · 1
Bond and Anderson, psychoeducation for relapse prevention in bipolar disorder, systematic review of efficacy in randomized controlled trials · Bipolar Disord 2015
Interpersonal and social rhythm therapy lengthened the well interval between episodes
A therapy that helps people keep steady daily and sleep routines did not speed up initial recovery, but it kept people well for longer between episodes.
In a randomized trial, people who received interpersonal and social rhythm therapy (IPSRT) in the acute phase went longer without a new mood episode over two years than those given intensive clinical management, even though the two groups reached remission at similar rates (70% versus 72%). IPSRT works by steadying daily rhythms, sleep, meals and social routines, on top of medication, which is one of the more direct levers in bipolar disorder because circadian disruption can precipitate episodes. Measured in: 175 adults with bipolar I disorder randomized to IPSRT or intensive clinical management. The two therapies reached remission at the same rate; IPSRT's advantage was in staying well afterward, and it is an adjunct to medication rather than a standalone treatment.
The study · 1
Frank et al., two-year outcomes for interpersonal and social rhythm therapy in individuals with bipolar I disorder · Arch Gen Psychiatry 2005
Omega-3 eased bipolar depression a little as an add-on, and did nothing for mania
Fish-oil omega-3, added to regular treatment, gave a small lift in bipolar depression but did nothing for mania, and the evidence is thin enough to treat it as a low-risk extra, not a real treatment.
Pooled analyses found that adjunctive omega-3 fatty acids produced a modest improvement in bipolar depressive symptoms (a significant but small effect size around 0.3), with the benefit tied to EPA-predominant formulations added on top of standard treatment. There was no benefit for manic symptoms. The depression finding rests on a small number of trials and shows signs of publication bias, so it is best read as a low-risk adjunct rather than a treatment in its own right. Measured in: Adults with bipolar disorder across pooled randomized trials of adjunctive omega-3 fatty acids. Few trials, heterogeneity between them, and evidence of publication bias make the effect uncertain; omega-3 does not treat mania and does not replace a mood stabilizer.
The study · 1
Sarris et al., omega-3 for bipolar disorder, meta-analyses of use in mania and bipolar depression · J Clin Psychiatry 2012
Social Connection
Family-focused therapy reduced relapse and rehospitalization over two years
When the family learns the illness together and works on communication, on top of medication, relapses and hospital stays drop over the following two years.
In a randomized trial, adding family-focused therapy (psychoeducation, communication training and problem-solving with the person and their relatives) to medication reduced mood relapses and rehospitalizations over two years compared with an individually focused treatment. The effect is thought to run partly through lowering high-conflict, high-criticism family environments that predict relapse, and partly through better recognition of early warning signs. Measured in: 53 recently hospitalized adults with bipolar disorder randomized to family-focused therapy (n=28) or individually focused treatment (n=25), all on mood-stabilizing medication. The trial was modest in size (53 patients), the two treatments may have differed in total contact time, and the approach depends on having involved family members, so it does not fit everyone's circumstances.
The study · 1
Rea et al., family-focused treatment versus individual treatment for bipolar disorder, results of a randomized clinical trial · J Consult Clin Psychol 2003;71(3):482-92
Sleep
Sleep loss and circadian disruption can precipitate mania, making sleep a treatment target
Losing sleep or having a scrambled daily rhythm can set off a manic episode, and a shift in sleep often comes before a shift in mood, which is why protecting sleep matters so much in bipolar disorder.
Multiple lines of evidence indicate that disrupted sleep can both predict and precipitate manic episodes: a change in the sleep pattern often precedes a change in mood, and deliberately curtailing sleep can tip some people with bipolar disorder into mania or hypomania. Because of this, stabilizing sleep and daily rhythm is treated as a core priority in bipolar disorder, both as a way to reduce relapse and as an early-warning signal to watch. Measured in: Reviews of experimental, observational and clinical studies of sleep and circadian function in bipolar disorder. This is review-level evidence assembling many smaller studies rather than a single large trial of sleep regularization for relapse prevention, and not everyone who loses sleep switches, so it describes a strong and consistent risk relationship rather than a fixed cause in every case.
The study · 1
Plante and Winkelman, sleep disturbance in bipolar disorder, therapeutic implications · Am J Psychiatry 2008
Where the Evidence Runs Thin
No supplement, diet, or routine substitutes for medication when someone has bipolar disorder. The self-directed levers on this page lower relapse and support recovery, and they matter, but the evidence does not support managing bipolar I or II without a mood stabilizer and psychiatric care. Omega-3 is a modest add-on for the depressive side and does nothing for mania. Chinese herbal medicine has a long traditional use for these presentations, covered below, but it has not been tested as a replacement for mood stabilizers, and it belongs alongside psychiatric care rather than in place of it. The research also has less to say about bipolar II than bipolar I, about the long stretches of maintenance rather than the acute episodes, and about how best to combine the self-directed levers with medication over a lifetime.
What To Do This Week
None of this replaces medication or a prescriber, and each of these works on top of psychiatric care. If you are between episodes, this is where steadiness is built.
The single largest driver of relapse is stopping medication, often when feeling well or missing the highs. If a medication is causing problems, that is a conversation with your prescriber about changing it, not a reason to stop on your own. Do not start or stop any medication because of anything on this page.
Hold a regular sleep and wake time, even on weekends, and keep meals and activity on a steady clock. Sleep loss can trigger mania, so a run of short nights is an early warning to act on, not to push through. This is the circadian logic that interpersonal and social rhythm therapy is built on.
Structured psychoeducation lowers relapse. Learn your personal signature of an episode building, the first changes in sleep, spending, speed, or mood, and write a plan for what you and one other person will do when they show.
Family-focused work lowers relapse partly by getting the people around you to recognize an episode early and to keep conflict low. Tell one person your early warning signs and what you want them to do if they notice them before you do.
Alcohol and drug use is common with bipolar disorder and can destabilize mood, disturb sleep, and interact with medication. Stimulants and heavy cannabis use can help set off mania. Cutting back is one of the levers in your hands.
A simple daily mood and sleep log turns a vague sense of "up" or "down" into a pattern you and your clinician can act on, and it catches an episode building before it takes hold.
Go Deeper
- Depression: the depressive pole overlaps with major depression, but the treatment differs, and telling them apart is what keeps an antidepressant from triggering mania.
- Insomnia: the sleep problems that both follow and worsen bipolar disorder, and the structured program that treats them.
- Morning light: bright light within an hour of waking, one of the tools for anchoring the daily rhythm that steadies mood.
- Social connection: staying in contact and keeping conflict low, part of what family-focused therapy works on.
- Omega-3 fish oil: the supplement in full, what it does, and where its evidence is strong and where it is thin.
- Anxiety: the most common companion of bipolar disorder, present in most people who live with it.
The Chinese Medicine View
The Chinese Medicine View
Chinese medicine reads the two poles of bipolar disorder through the old category of dian kuang (癫狂), where dian is the withdrawn, dull, unresponsive picture and kuang is the agitated, excited, sleepless one. The tradition tends to place Phlegm at the root, clouding the Mind in the dian phase, and Fire, often from the Liver and Heart, blazing upward with the Phlegm to agitate the Mind in the kuang phase, on a background of Yin and Yang out of balance. Hold this as an interpretive lens on constitution and circumstance, not a translation of a diagnosis or a rating scale, and not a claim that the tradition anticipated modern psychiatry. The tradition itself is cautious here: these are among the most serious patterns it describes, the formulas differ from person to person and phase to phase, and any herbs belong with a qualified practitioner and a traceable supply. In this illness Chinese medicine sits alongside psychiatric care as an adjunct, never as a replacement for a mood stabilizer, and some herbs can interact with the medications on this page.
Agitation, a racing and pressured mind, insomnia, a red face, a bitter taste, a rapid wiry pulse, and a red tongue with a greasy yellow coat. This is the kuang picture, and the classical direction is to clear Fire, transform Phlegm, and calm the Mind.
Dullness, apathy, muddled or incoherent speech, indifference, and a thick greasy tongue coat. This is the dian picture, attributed to Phlegm obstructing the orifices of the Heart, and the direction is to transform Phlegm and open the Mind.
Tension and irritability that build and then flare into anger, a bitter taste, red eyes, disturbed sleep, and a wiry pulse. Long-standing constraint that has generated heat, treated by moving the Liver Qi and clearing the heat, often layered on one of the other patterns.
Exhaustion that rest does not fix, poor appetite, palpitations, poor memory, broken sleep, and a pale tongue, more prominent in the depleted, depressive stretches between episodes. Attributed to prolonged overthinking depleting the Heart and Spleen, and strengthened rather than drained.
Restlessness, waking in the small hours, night sweats, heat in the palms and soles, a dry mouth, and a red tongue with little coat. A depleted, overheated picture that can follow a long or intense episode, treated by nourishing Yin and settling the Mind.
Acupuncture belongs with this lens rather than with the trial evidence: it has a long traditional use for calming the Mind and steadying sleep, and it is a reasonable adjunct for someone drawn to it, sitting alongside psychiatric care rather than in place of it. There is no trial evidence that it treats bipolar disorder itself.
Cautions With Bipolar Disorder
Extra restraintEverything to be aware of is here, in one place. This practice suits most healthy people; a few situations call for real care.
Lithium lowered suicide and total deaths versus placebo across mood disorders
Pooling 48 randomized controlled trials, lithium reduced the number of suicides and of deaths from any cause compared with placebo in people with unipolar and bipolar mood disorders, and reduced deliberate self-harm in unipolar depression. It is the one mood treatment with randomized evidence pointing to an anti-suicide effect, which is why guidelines highlight it for people at raised suicide risk. Suicide is a rare event, so individual trials were underpowered for it: a later meta-analysis restricted to the suicide outcome found the difference did not reach statistical significance (odds ratio 0.41, 95% CI 0.03 to 2.49). The signal is supported by observational and registry data, and lithium is not started to prevent suicide on its own but as a mood stabilizer that also carries this benefit.Cipriani et al., lithium in the prevention of suicide in mood disorders, updated systematic review and meta-analysisNabi et al., effects of lithium on suicide and suicidal behaviour, systematic review and meta-analysis of randomised trials
Antidepressants triggered a switch into mania in roughly 15% to 30% of bipolar depression
In a systematic review and meta-analysis of bipolar depression, treatment-emergent mania or hypomania occurred in about 15% of people in prospective studies and about 31% in retrospective studies exposed to antidepressants. The risk was higher with antidepressant monotherapy than when an antidepressant was combined with a mood stabilizer such as lithium or with a second-generation antipsychotic, and higher for older antidepressant classes. This is why current guidelines caution against using an antidepressant alone in bipolar disorder. Rates varied widely with study design, how a switch was defined, and the length of follow-up, and telling a genuine drug-induced switch from the illness's own course is difficult, so the exact figure is uncertain even though the direction is consistent.Fornaro et al., incidence, prevalence and clinical correlates of antidepressant-emergent mania in bipolar depression, systematic review and meta-analysis
An antidepressant alone can trigger mania
This is the safety point that matters most. An antidepressant taken without a mood stabilizer can tip a person with bipolar disorder into mania or hypomania, and this happens to a meaningful share of people. It is the main reason getting the diagnosis right matters before treatment is chosen, and why antidepressants in bipolar disorder are used cautiously, usually only alongside a mood stabilizer, and never as the sole treatment. If low mood has ever been broken by spells of unusual energy or little need for sleep, tell your prescriber before an antidepressant is started.
Lithium has a narrow safe range and needs monitoring
Lithium is one of the best-evidenced treatments in psychiatry, and it works because it is used carefully. The helpful blood level sits close to the toxic one, so it needs periodic blood tests, and it can affect the thyroid and kidneys over the years, which are checked routinely. Dehydration, some painkillers (NSAIDs), and certain blood-pressure medicines can push the level up. Signs of toxicity, such as a coarse tremor, vomiting, diarrhea, confusion, or unsteadiness, need same-day medical attention.
Some mood medications are harmful in pregnancy
Valproate carries a high risk of serious birth defects and developmental problems and is not used in people who can become pregnant unless there is no alternative and strict precautions are in place. Lithium carries a smaller risk of a specific heart defect. Anyone with bipolar disorder who is pregnant or planning a pregnancy needs the medication plan reviewed with a clinician in advance, because both stopping medication and continuing it carry risks that have to be weighed together.
Lamotrigine must be started slowly
Lamotrigine can cause a rare but serious rash (Stevens-Johnson syndrome), and the risk is reduced by increasing the dose slowly as prescribed. Any spreading rash, blistering, or a rash with fever or mouth sores after starting lamotrigine needs urgent medical attention.
St John's wort, stimulants, and recreational drugs can destabilize mood
St John's wort can interact with many medications and has been reported to trigger mania, so it is not a safe self-prescribed option here. Stimulants, heavy cannabis use, and alcohol can help set off episodes and disturb the sleep that keeps mood steady. Tell your prescriber everything you take, prescription and not, including herbs and supplements.
Do not stop medication abruptly
Stopping a mood stabilizer suddenly, lithium in particular, can bring on a relapse, sometimes a severe one. Feeling well is not a sign the medication is no longer needed; it is usually a sign it is working. Any change is a plan to make with your prescriber, tapered where appropriate, not a decision to act on alone.
Start slow, be smart, read the research, and consult a professional if you have any concerns. This is here to inform your choice, not make it for you.
When to See Someone
Bipolar disorder is treatable and most people reach long periods of stability, and a few of the signs below need help the same day. If you are thinking about suicide, or about harming yourself, or if someone in a manic episode is in danger, treat it as a medical emergency: call your local emergency number, go to an emergency department, or call the suicide and crisis line your own country's health service publishes. Crisis numbers differ from country to country, so use the one your health service lists. One rule sits above all of this: do not start or stop a medication because of anything on this page.
- A suicide attempt, an overdose of any size, or a new plan or stated intention to end your life(seek urgent care)
- A manic episode with psychosis, losing contact with reality, or behavior that puts you or others in danger, which can need hospital care(seek urgent care)
- Mania or psychosis in a new mother, which is postpartum psychosis, a psychiatric emergency that needs assessment the same day(seek urgent care)
- Signs of lithium toxicity such as a coarse tremor, vomiting, diarrhea, slurred speech, confusion, or unsteadiness, which need same-day medical attention(seek urgent care)
- A spreading or blistering rash, or a rash with fever or mouth sores, after starting lamotrigine, which needs urgent assessment(seek urgent care)
- A swing into unusual energy, racing thoughts, little need for sleep, fast speech, or reckless spending or decisions, especially soon after starting an antidepressant, which points to a manic switch and needs a prescriber review
- Low mood or loss of interest most of the day, most days, for two weeks or more, which is a reason to seek help, and to mention any past spells of unusual energy so the diagnosis is got right before treatment
- A run of short or broken nights, which in bipolar disorder can be the first sign of an episode building rather than a minor sleep problem
None of this is here to frighten you. Bipolar disorder responds to treatment, and the combination of the right medication, steady routines, and people who know your early warning signs keeps most people well for long stretches. Reaching for help early is the ordinary thing to do. When in doubt, tell your prescriber.
Common Questions
Is lithium still the best treatment for bipolar disorder?
For long-term stability, lithium remains the treatment with the strongest and longest evidence, and it is first-line in current guidelines. Taken steadily it cuts relapse by roughly a third, protects against manic episodes more reliably than depressive ones, and is the one mood treatment with randomized evidence linked to a lower risk of suicide. It needs periodic blood tests, because the safe range is narrow, and monitoring of the thyroid and kidneys. It is not the only option, and the right choice depends on the person, but it is the benchmark the others are measured against.
Can I manage bipolar disorder with lifestyle instead of medication?
No. The self-directed levers on this page, protecting sleep, keeping a steady rhythm, learning the illness, involving people you trust, are real and they lower the relapse rate, but they work on top of a mood stabilizer and psychiatric care, not instead of them. The largest single cause of relapse is stopping medication, often when feeling well. Bipolar disorder is a lifelong illness where the medication is what holds the floor, and the daily levers make that floor steadier.
Why can't I just take an antidepressant for the low phases?
Because an antidepressant can tip a person with bipolar disorder into mania, especially when taken without a mood stabilizer, and even added on top of one it only nudges bipolar depression a little without helping more people actually recover. The depressed phase of bipolar disorder is treated differently from ordinary depression: with mood stabilizers such as lithium and lamotrigine, and antipsychotics such as quetiapine, lurasidone, or cariprazine. This is also why any history of manic or high-energy spells needs telling before an antidepressant is ever started.
Does fixing my sleep really matter that much?
Yes, more than almost anything else you steer yourself. Disrupted sleep both predicts and can precipitate mania, and a change in the sleep pattern often comes before a change in mood, so a run of short nights is an early warning to act on. Holding a regular sleep and wake time, and steady meals and activity, is the circadian logic that interpersonal and social rhythm therapy is built on, and it is one of the levers in your hands. It supports the medication rather than replacing it.
Does omega-3 or any supplement help?
Omega-3 fatty acids, added to standard treatment, give a small improvement in the depressive side of bipolar disorder and do nothing for mania, and the evidence is thin enough to treat them as a low-risk extra rather than a treatment. No supplement replaces a mood stabilizer. St John's wort is best avoided here, because it interacts with many medications and has been reported to trigger mania. Tell your prescriber about anything you take, including herbs and supplements, since some interact with the medications that keep mood steady.
Does Chinese medicine treat bipolar disorder?
Chinese medicine has a long tradition of reading these two poles as dian kuang and treating them with herbs and acupuncture matched to the pattern, and that care can sit alongside psychiatric treatment for someone drawn to it. It has not been tested as a replacement for mood stabilizers, and it is not one: this is a serious illness where the medication holds the floor. Any herbs belong with a qualified practitioner and a traceable supply, and your prescriber should know about them, because some can interact with your medication.
Explore Related
Other pages this one connects to, by the evidence they share, the outcomes they touch, and the ground they cover.
All 14 sources on this page independently checked and cross-referenced.
Thomas Dehli, Founder & Editor, Sacred Lotus
Sacred Lotus has published Chinese medicine reference material since 2001. Integrative pages are held to the same standard as the herb and formula library: cite the source, grade the claim at its real strength, and say where the research has not looked. This page is educational and it is not medical advice. Last reviewed and updated August 15, 2026.
Evidence strength
How confidently the research supports a claim. Strength describes the evidence, not our endorsement.